0,888  0,007  Transcription factor NF kappa B inhibitor
0,881  0,006  Antiinflammatory
0,875  0,003  Sensitization
0,862  0,009  Apoptosis agonist
0,851  0,005  Antileukemic
0,824  0,004  Antineoplastic (glioma)
0,794  0,004  Antineoplastic (glioblastoma multiforme)
0,796  0,009  Antineoplastic (breast cancer)
0,776  0,004  Nitric oxide antagonist
0,745  0,013  Antineoplastic (lung cancer)
0,734  0,012  Antineoplastic (colorectal cancer)
0,726  0,012  Antineoplastic (colon cancer)
0,696  0,005  Hepatic disorders treatment
0,674  0,005  Antineoplastic (multiple myeloma)
0,672  0,005  Antineoplastic (pancreatic cancer)
0,669  0,021  CYP3A4 substrate
0,633  0,013  Antineoplastic (ovarian cancer)
0,606  0,012  Immunosuppressant
0,597  0,005  Antineoplastic (liver cancer)
0,602  0,018  Prostate cancer treatment
0,593  0,011  NOS2 expression inhibitor
0,586  0,011  Apoptosis antagonist
0,587  0,014  Antineoplastic (cervical cancer)
0,575  0,010  Antipyretic
0,561  0,004  Platelet adhesion inhibitor
0,555  0,013  Antiparasitic
0,555  0,015  Cytostatic
0,535  0,009  Antihelmintic
0,528  0,014  Antiprotozoal (Leishmania)
0,531  0,020  Antineoplastic (melanoma)
0,514  0,007  Antiulcerative
0,533  0,029  Teratogen
0,513  0,009  Antineoplastic (renal cancer)
0,519  0,024  Bone diseases treatment
0,505  0,020  Mutagenic
0,499  0,019  Chemopreventive
0,480  0,010  Antineoplastic (lymphocytic leukemia)
0,477  0,016  ICAM1 expression inhibitor
0,459  0,023  Cardiovascular analeptic
0,461  0,035  Embryotoxic
0,422  0,004  T cell inhibitor
0,447  0,033  Antifungal
0,442  0,029  Antiosteoporotic
0,439  0,030  Antineoplastic (brain cancer)
0,445  0,039  Antithrombotic
0,448  0,048  CYP2C9 substrate
0,413  0,022  Antidiabetic symptomatic
0,388  0,007  Diabetic nephropathy treatment
0,389  0,010  Antialcoholic
0,439  0,061  Antibacterial
0,378  0,012  Prostate disorders treatment
0,398  0,033  Antineoplastic (non-small cell lung cancer)
0,390  0,028  Antineoplastic (lymphoma)
0,401  0,041  CYP2C19 substrate
0,445  0,086  Caspase 9 stimulant
0,368  0,016  Hepatoprotectant
0,389  0,037  Cytotoxic
0,412  0,062  Antipruritic, allergic
0,413  0,063  GST A substrate
0,377  0,039  Antioxidant
0,352  0,025  Abortion inducer
0,339  0,017  Prostatic (benign) hyperplasia treatment
0,398  0,078  TNF expression inhibitor
0,367  0,048  NOS3 expression inhibitor
0,332  0,013  Liver fibrosis treatment
0,351  0,038  Carcinogenic
0,343  0,046  UGT2B4 substrate
0,339  0,047  Sodium/bile acid cotransporter inhibitor
0,345  0,054  Cardioprotectant
0,302  0,013  Antidiarrheal
0,302  0,017  Neurotrophic factor enhancer
0,305  0,021  Antineoplastic (carcinoma)
0,304  0,021  Antineoplastic (squamous cell carcinoma)
0,282  0,005  Aromatase inhibitor
0,298  0,023  Contraceptive
0,291  0,023  Antiacne
0,321  0,053  Antineoplastic (endocrine cancer)
0,289  0,022  Interferon gamma antagonist
0,290  0,029  UGT2B7 substrate
0,285  0,034  Antiviral (Influenza)
0,299  0,053  Proliferative diseases treatment
0,272  0,036  VCAM1 expression inhibitor
0,289  0,055  Free radical scavenger
0,257  0,027  Hair growth stimulant
0,288  0,063  Transcription factor STAT inhibitor
0,269  0,046  Antineoplastic enhancer
0,248  0,025  Antiviral (Influenza A)
0,249  0,029  Melanin inhibitor
0,295  0,079  Respiratory analeptic
0,221  0,009  Opioid kappa receptor antagonist
0,278  0,067  Antiprotozoal (Trypanosoma)
0,319  0,111  CYP2C19 inhibitor
0,220  0,017  Farnesoid X receptor antagonist
0,286  0,091  AR expression inhibitor
0,233  0,039  Lipocortins synthesis antagonist
0,192  0,005  Opioid kappa receptor agonist
0,192  0,004  Hypercalcemia treatment
0,238  0,053  UDP-glucuronosyltransferase substrate
0,274  0,091  Analeptic
0,198  0,016  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,187  0,008  CDC25A inhibitor
0,203  0,030  Arachidonic acid antagonist
0,242  0,072  DNA synthesis inhibitor
0,255  0,088  Lipoprotein disorders treatment
0,183  0,020  Alcohol dehydrogenase substrate
0,194  0,034  Antifungal enhancer
0,169  0,012  Inducible nitric-oxide synthase inhibitor
0,167  0,011  Anabolic
0,179  0,025  Microtubule formation inhibitor
0,214  0,062  Pneumotoxic
0,230  0,082  Platelet antagonist
0,241  0,095  Renal disease treatment
0,203  0,059  Antipruritic, non-allergic
0,198  0,059  UGT1A4 substrate
0,245  0,106  GST M1-1 substrate
0,145  0,008  Bile acid receptor antagonist
0,206  0,071  Anesthetic general
0,225  0,093  Antineoplastic (sarcoma)
0,271  0,145  Antiprotozoal
0,137  0,011  Glycine receptor antagonist
0,181  0,055  UGT2B10 substrate
0,226  0,103  5 Hydroxytryptamine release stimulant
0,192  0,070  Sepsis treatment
0,241  0,121  Caspase 3 stimulant
0,225  0,106  Transcription factor STAT3 inhibitor
0,137  0,021  Paget's disease treatment
0,148  0,032  TRPA1 agonist
0,128  0,012  Na+ K+ transporting ATPase inhibitor
0,149  0,034  Contraceptive female
0,192  0,078  UGT1A1 substrate
0,146  0,035  Mucolytic
0,166  0,058  Protein kinase stimulant
0,222  0,114  5 Hydroxytryptamine uptake stimulant
0,207  0,103  Tumour necrosis factor alpha release inhibitor
0,112  0,015  Glycine receptor agonist
0,132  0,035  Antineoplastic antibiotic
0,122  0,032  UGT2B11 substrate
0,127  0,038  Electron transport complex I inhibitor
0,115  0,028  Chymotrypsin inhibitor
0,131  0,044  Expectorant
0,118  0,032  Thioredoxin inhibitor
0,147  0,062  Neurotrophic factor
0,227  0,143  Cholesterol antagonist
0,133  0,054  Monophenol monooxygenase inhibitor
0,199  0,121  Immunostimulant
0,148  0,070  UGT2B15 substrate
0,087  0,010  Estrogen receptor alpha agonist
0,109  0,032  Transcription factor NF kappa B stimulant
0,114  0,039  Opioid antagonist
0,113  0,038  Androgen antagonist
0,108  0,035  Acetylcholine nicotinic antagonist
0,102  0,031  Vanilloid agonist
0,136  0,066  Skin whitener
0,082  0,012  5-Alpha-reductase inhibitor
0,222  0,152  Vasodilator, peripheral
0,160  0,091  Toxic, respiratory center
0,070  0,004  Vitamin D receptor antagonist
0,126  0,060  Cholesterol synthesis inhibitor
0,146  0,081  UGT2B9 substrate
0,179  0,119  Antihypercholesterolemic
0,162  0,102  Non-steroidal antiinflammatory agent
0,143  0,085  Eye irritation, high
0,189  0,132  Radioprotector
0,145  0,088  Sigma receptor agonist
0,142  0,089  UGT1A3 substrate
0,126  0,075  Vanilloid 1 agonist
0,087  0,037  Narcotic antagonist
0,060  0,011  Parathyroid hormone antagonist
0,155  0,107  Septic shock treatment
0,119  0,071  Carcinogenic, group 3
0,115  0,068  Shock treatment
0,068  0,023  Lipocortins synthesis agonist
0,094  0,051  Antineoplastic alkaloid
0,067  0,024  Postcoital contraceptive
0,068  0,027  Estrogen agonist
0,077  0,036  Anticholelithogenic
0,077  0,039  Neuronal nicotinic receptor antagonist
0,044  0,009  Cyclophilin A inhibitor
0,041  0,007  CYP24 inhibitor
0,062  0,028  Opioid agonist
0,131  0,097  Pregnane X receptor agonist
0,091  0,058  Actinic keratosis treatment
0,134  0,101  Ca2+-transporting ATPase inhibitor
0,111  0,081  Aldehyde dehydrogenase inhibitor
0,114  0,084  Acetylcholinesterase inhibitor
0,078  0,048  Antibiotic
0,100  0,071  UGT2B1 substrate
0,054  0,025  Aldosterone antagonist
0,184  0,158  Flavin-containing monooxygenase substrate
0,146  0,121  Antiviral (Hepatitis)
0,195  0,170  Immunomodulator
0,038  0,014  Calcium-independent phospholipase A2 inhibitor
0,039  0,017  RNA-directed RNA polymerase stimulant
0,043  0,021  Estrogen receptor beta agonist
0,116  0,094  Interleukin 1 antagonist
0,055  0,034  Elastase inhibitor
0,050  0,029  Microtubule stabilization
0,064  0,044  Antiemphysemic
0,119  0,100  Antiischemic, cerebral
0,024  0,007  Prostacyclin agonist
0,178  0,162  Chemoprotective
0,091  0,076  Nitric-oxide synthase inhibitor
0,035  0,022  Tubulin agonist
0,053  0,040  Postmenopausal disorders treatment
0,021  0,010  Progesterone receptor B antagonist
0,139  0,128  LDLR expression enhancer
0,035  0,023  HMG CoA reductase inhibitor
0,132  0,122  Sedative
0,054  0,046  HIV-1 integrase (Strand Transfer) inhibitor
0,055  0,049  Androgen agonist
0,065  0,060  Lipase inhibitor
0,095  0,091  DNA polymerase I inhibitor
0,105  0,101  Bone formation stimulant
0,135  0,131  Psychostimulant
0,021  0,018  Prostaglandin F2 alpha agonist
0,016  0,013  Vitamin D receptor agonist
0,234  0,231  Antidiabetic
0,234  0,231  Cyclophilin D inhibitor
0,012  0,010  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,046  0,044  Protein 50S ribosomal subunit inhibitor
0,019  0,018  Corticosteroid-like
0,027  0,027  Prostaglandin D2 agonist
0,085  0,084  Skin irritative effect

